About Us

Anatomise Biostats is a boutique biometrics consultancy dedicated to advancing medtech innovation through specialised biostatistics and bioinformatics. We focus on helping medtech firms bring their diagnostic and therapeutic devices to market with confidence. Our tailored statistical solutions evolve with your project, covering everything from trial design and data analysis to regulatory-ready reporting.

We take a multi-disciplinary approach and keep up-to date with the latest analysis techniques, such as Bayesian modelling and network analysis, so that we can provide the most comprehensive statistical services to suit evolving client needs.

    Who We Work With

    Medtech Start-ups and SMEs

    Developing new diagnostic or therapeutic devices. Our role is to assist with the R&D and regulatory approval process enabling products to safely benefit patients.

    Clinical and Biomedical Researchers

    Running studies to gather insights that support findings and advance medical knowledge.

    Legal and Advisory Professionals

    Running studies to gather insights that support findings and advance medical knowledge.

    Our goal is to serve as your dedicated, outsourced biometrics team, providing customised support that includes a highly experienced lead biostatistician, statistical programmers, and full project management for the biometrics side of your clinical trial. We bring the expertise and continuity needed to guide your study from design through to analysis, managing each step with precision and ensuring insights are aligned with your project’s goals.

    Our biostatisticians will perform independent audit of any study design, data collection related methodology, statistical analyses or reported findings that have arisen prior to our involvement. We can also aid in the interpretation of any existing study results.

    Our modular pricing approach for clinical trials allows ensures cost is known upfront while allowing a flexible solution tailored to your project’s specific requirements:

    Core Services: Our core clinical trials package covers essential biostatistics, quality control, and statistical programming for clinical trials. This means you have a dedicated and pre-vetted biostatistics team for your clinical trial, without the need to spend months recruiting and onboarding individuals. This is billed in six-month instalments to align with your project’s timeline.

    Add-On Services: Enhance your core package by adding specialised services such as bioinformatics or data science for £50,000 per annum. These can be selected based on your project’s unique needs.

    Our modular approach to pricing was implemented in response to feedback from industry and is designed to simplify the clinical trial process and enhance transparency around service costs.

    • Increase cost-effectiveness and optimise research budget
    • Streamline the execution of clinical trials with enhanced efficiency.
    • Reduce your risk of pursuing un-productive research trajectories.
    • Increase precision to ensure the insights from your research are as accurate as possible

    We support clients by:

    Our consultants are experts across a wide range of clinical sciences, including oncology, rare disease, haematology, medical and diagnostic devices, orthodontics, neuroscience, genomic analysis, and clinical psychology.

    • Designing clinical studies, including power and sample size calculations.
    • Developing statistical analysis plans (SAPs).
    • Conducting thorough statistical analyses and generating publication-ready reports (SARs).
    • Supporting regulatory approval of novel therapeutics via clinical trials and pilot studies.

    For legal clients, we offer scoping reviews, meta-analysis, and the development of advanced statistical models.

    At Anatomise Biostats we take a modern and dynamic approach to research collaboration.
    The field of medicine and the scope of associated research areas encompass an increasingly broad domain. As knowledge and technology expands, many different sub-disciplines are emerging that previously had not existed, and research areas are becoming highly intricate and specialised.  In addition to this, a multidisciplinary landscape is emerging with previously disparate areas of study merging to constitute entirely new domains.

    In an attempt to address this and to provide the highest standards of service to clients, we have taken the philosophy of medical specialisation and applied it to our biostatistical services. We employ the services of a number of highly specialised biostatisticians who take on the bulk of their projects within a single field. Due to the ever increasing complexity of data and the associated analytical approaches required to satisfactorily extract insights, we believe that this is by far the best approach. As we have specialists in multiple fields, this expertise can be combined to address research questions that blur the bounds of previously distinct sub-disciplines.

    We take pride in contributing to clinical and life sciences research that is of high integrity and impeccable standard so that insights from future research continue to be built upon a solid foundation.

    Biotechnology Consultancy Firm of the Year 2024/25
    Medical Technology Company of the Year 2023/24, Biotechnology Consultancy Firm of the Year 2023/24.